Question 1

How does BioNTech (Germany) rank in research?

Accepted Answer

BioNTech (Germany) ranks #8,743 of 22,385 institutions worldwide on research quality in 2022-now (#6,071 all time), and #289 of 795 in Germany.

Question 2

Who are the top researchers at BioNTech (Germany)?

Accepted Answer

Ranked on the quality score, Uğur Şahin, Alexander Muik and Mathias Vormehr lead among researchers whose main affiliation is BioNTech (Germany).

Question 3

What are the most cited papers from BioNTech (Germany)?

Accepted Answer

The most cited paper from BioNTech (Germany) is "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer" (Uğur Şahin et al., 2017), with 2,536 citations. Next come "mRNA-based therapeutics — developing a new class of drugs" (2,505) and "COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses" (2,072).

Question 4

Which research topics does BioNTech (Germany) publish most on?

Accepted Answer

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Question 5

Which keywords describe research at BioNTech (Germany)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunity, Vaccine, SARS-CoV-2, Cancer Immunotherapy, Pandemic, Coronavirus, ACE2 Receptor and Immunotherapy.

Question 6

Which fields of science does BioNTech (Germany) work in?

Accepted Answer

In 2022-now, 46% of research at BioNTech (Germany) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (11%). It does 2.7× the world's share of Life Sciences.

Question 7

Is BioNTech (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 71% higher than in 2018-2021.